Email
Print
1. Norovirus Vaccines Market- Market Overview
1.1 Definitions and Scope
2. Norovirus Vaccines Market- Executive Summary
3. Norovirus Vaccines Market- Landscape
3.1 Comparative analysis
3.1.1 Market Share Analysis- Top Companies
3.1.2 Product Benchmarking- Top Companies
3.1.3 Top 5 Financials Analysis
3.1.4 Patent Analysis- Top Companies
3.1.5 Pricing Analysis
4. Norovirus Vaccines Market- Market Forces
4.1 Market Drivers
4.2 Market Constraints
4.3 Market Opportunities
4.4 Porters five force model
4.4.1 Bargaining power of suppliers
4.4.2 Bargaining powers of customers
4.4.3 Threat of new entrants
4.4.4 Rivalry among existing players
4.4.5 Threat of substitutes
5. Norovirus Vaccines Market -Strategic analysis
5.1 Value chain analysis
5.2 Opportunities analysis
5.3 Market life cycle
5.4 Suppliers and distributors Analysis
6. Norovirus Vaccines Market– By Type (Market Size -$Million)
6.1 Norovirus P particle combination vaccine
6.2 Norovirus VLP vaccine
6.3 Transgenic plant-based norovirus vaccine
6.4 Recombinant adenovirus based vaccine
6.5 Trivalent norovirus/ rotavirus combination vaccine
7. Norovirus Vaccines Market - By Geography (Market Size -$Million)
7.1 North America
7.1.1 U.S.
7.1.2 Canada
7.1.3 Mexico
7.2 South America
7.2.1 Brazil
7.2.2 Argentina
7.2.3 Rest of South America
7.3 Europe
7.3.1 U.K
7.3.2 Germany
7.3.3 Italy
7.3.4 France
7.3.5 Spain
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 China
7.4.2 India
7.4.3 Japan
7.4.4 South Korea
7.4.5 Australia & New Zealand
7.4.6 Rest of Asia Pacific
7.5 RoW
7.5.1 Middle East
7.5.2 Africa
8. Soft Actuator Market- Entropy
8.1 New Product Launches
8.2 M&A’s, Collaborations, JVs and Partnerships
9. Norovirus Vaccines Market - Company Analysis (Market Share, Company Revenue, Products, M&A, Developments)
9.1 Takeda Pharmaceutical Company
9.2 Calici Therapeutics
9.3 Cocrystal Pharma, Inc.
9.4 HilleVax
9.5 Icon Genetics GmbH
9.6 PanTheryx
9.7 Vaxart and more
"*Financials would be provided on a best efforts basis for private companies"